Ostatní
Návod 
Utah Medical Products, Inc.
UTMD
Souhrn
Výkazy
Ukazatele
Profil
Držitelé
Návštěvnost webu
Konkurence
Zprávy společnosti
Kapitalizace
0.2B
Obrat
0B
Zisk
0B
Aktiva
0B
Dluh
0B
ROE
0%
ROA
0%
PE
18
PS
5
Cena 1R
51-66
⌀ Cena
57.29
Dividenda
0.0(0.0%)
Čtvrtletní 10-Q
Celoroční 10-K
Nadcházející oznámení zisků
28-04-2026
Poslední dividenda
17-03-2026
Profil
Společnost Utah Medical Products, Inc. vyvíjí, vyrábí a distribuuje zdravotnické prostředky pro zdravotnický průmysl. Společnost nabízí fetální monitorovací příslušenství, vakuově asistované rozváděcí systémy a další pracovní a rozváděcí nástroje; dětské dýchací digestoře DISPOSA-HOOD a systémy monitorující krevní tlak DELTRAN PLUS. Poskytuje také GESCO umbilické cévní katétry; DIALY-NATE jednorázové peritoneální dialyzační sady; PALA-NATE silikonové orální ochranné prostředky; URI-CATH močové drenážní systémy; NUTRI-CATH\NUTRI-LOK krmné zařízení; MYELO-NATE lumbální vzorkovací soupravy; jednorázové filtry HEMO-NATE; a katetrizační proceduru zásobník nástrojů a potřeb. Kromě toho společnost nabízí systém LETZ pro excizi cervikální intraepiteliální neoplazie a dalších lézí dolních pohlavních orgánů; generátory FINESSE+; elektrody smyček, míčků a jehel; evakuátory FILTRESSE; další speciální elektrody a potřeby a gynekologické nástroje; dámské vozíky, kanóny, laparoskopické nástroje a příslušenství; a elektrochirurgické přístroje EPITOME a OptiMicro. Dále poskytuje ženské chirurgické antikoncepční prostředky Filshie Clip, endoskopické zavlažovací prostředky PATHFINDER PLUS, suprapubickou katetrizaci, systémy léčby a kontroly inkontinence moči LIBERTY, ENDOCURETTE, kyretu pro odběr vzorků endometriální tkáně dělohy, TVUS/HSG-Cath pro hodnocení abnormálního nebo dysfunkčního krvácení dělohy a dalších abnormalit dělohy a LUMIN nástroj pro manipulaci s dělohou při laparoskopických procedurách. Společnost dále nabízí společnost DELTRAN, jednorázový snímač tlaku; a příslušenství, komponenty a další tvarované díly pro monitorování tlaku. Slouží novorozeneckým jednotkám intenzivní péče, pracovnímu a realizačnímu oddělení, ženským zdravotním střediskům v nemocnicích, ambulantním klinikám a ordinacím lékařů prostřednictvím přímých zákaznických služeb a prodejců, nezávislých konzultantů a zástupců výrobců. Společnost byla založena v roce 1978 a sídlí v Midvale v Utahu.
Sektor
Healthcare
Odvětví
Medical - Instruments & Supplies
Počet zaměstnanců
155
Založení
1999-03-08
Podobné společnosti
$ 5.19
+ $ 0.27
$ 2.41
+ $ 0.02
$ 3.86
- $ 0.04
$ 9.94
+ $ 0.02
$ 2.20
+ $ 0.01
$ 2.17
- $ 0.03
$ 6.14
+ $ 0.18
Zahraniční články
Výsledovka
Rozvaha
Peněžní toky
Výsledovka
Výsledovka
Rozvaha
Peněžní toky
V miliónech (USD)
| Revenue | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Revenues | 38.5 | 38.5 | 40.9 | 50.2 | 52.3 | 49.1 | 42.2 | 46.9 | 42.0 | 41.4 | 39.3 | 40.2 | 41.3 | 40.5 | 41.6 | 37.9 | 25.1 | |
| Cost of Revenues | 18.1 | 18.6 | 16.8 | 20.2 | 20.1 | 18.1 | 16.6 | 17.4 | 15.7 | 15.0 | 15.6 | 16.0 | 16.3 | 16.2 | 16.2 | 15.5 | 11.9 | |
| Gross Profit | 20.4 | 19.9 | 24.1 | 30.0 | 32.2 | 30.9 | 25.5 | 29.5 | 26.3 | 26.4 | 23.7 | 24.2 | 25.0 | 24.3 | 25.3 | 22.4 | 13.2 |
| Revenue | 4-2025 | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Revenues | 9.0 | 9.8 | 10.0 | 9.7 | 9.2 | 10.0 | 10.4 | 11.3 | 12.3 | 12.5 | |
| Cost of Revenues | 4.3 | 4.8 | 4.9 | 4.2 | 3.8 | 4.7 | 4.7 | 4.6 | 6.1 | 5.1 | |
| Gross Profit | 4.7 | 5.1 | 5.1 | 5.5 | 5.3 | 5.3 | 5.7 | 6.8 | 6.2 | 7.4 |
| Operating Income | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| R&D Expenses | 0.0 | 0.0 | 0.0 | 0.6 | 0.5 | 0.5 | 0.5 | 0.5 | 0.5 | 0.4 | 0.5 | 0.5 | 0.5 | 0.5 | 0.6 | 0.5 | 0.4 | |
| Selling General & Admin Expenses | 0.0 | 0.0 | 0.0 | 12.7 | 11.9 | 11.5 | 11.4 | 11.4 | 7.2 | 6.9 | 7.0 | 8.0 | 8.3 | 9.0 | 9.5 | 10.0 | 3.9 | |
| Depreciation & Amortization | 3.0 | 3.0 | 2.8 | 6.4 | 7.1 | 12.0 | 7.2 | 6.9 | 3.0 | 2.8 | 2.8 | 3.1 | 3.4 | 3.2 | 3.3 | 2.8 | 0.6 | |
| Total Operating Expenses | 9.0 | 8.5 | 10.5 | 13.3 | 12.4 | 12.0 | 11.8 | 11.8 | 7.6 | 7.4 | 7.5 | 8.5 | 8.8 | 9.4 | 10.1 | 10.6 | 4.3 | |
| Operating Income | 11.4 | 11.4 | 13.6 | 16.8 | 12.7 | 18.9 | 6.5 | 10.8 | 18.7 | 19.0 | 16.2 | 15.7 | 16.2 | 14.8 | 15.2 | 11.8 | 8.9 |
| Operating Income | TTM | 4-2025 | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| R&D Expenses | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.1 | 0.1 | ||
| Selling General & Admin Expenses | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 2.1 | 3.3 | ||
| Depreciation & Amortization | 0.7 | 0.8 | 0.7 | 0.7 | 0.7 | 0.7 | 0.7 | 0.7 | 1.0 | 1.8 | ||
| Total Operating Expenses | 2.3 | 2.4 | 1.9 | 2.4 | 2.4 | 1.9 | 2.3 | 2.9 | 2.3 | -3.4 | ||
| Operating Income | 2.4 | 2.6 | 3.2 | 3.2 | 2.9 | 3.3 | 3.4 | 3.9 | 3.9 | 4.0 |
| Net Income | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Interest Income | 0.0 | 0.0 | 3.4 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Interest Expense | 0.0 | 0.0 | 0.0 | 0.0 | -0.9 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.1 | 0.3 | 0.4 | 0.7 | 0.9 | 0.0 | |
| Other Expense | 2.7 | 2.7 | 3.2 | 3.3 | 8.0 | 0.2 | 7.3 | 7.1 | 0.8 | 0.1 | 0.2 | 0.0 | -0.1 | 0.1 | 0.0 | 0.1 | 0.1 | |
| IBT | 14.1 | 14.1 | 16.8 | 20.1 | 20.7 | 19.1 | 13.8 | 17.9 | 19.5 | 19.1 | 16.4 | 15.5 | 15.8 | 14.5 | 14.5 | 11.1 | 9.0 | |
| Income Tax Expense | 2.8 | 2.8 | 2.9 | 3.5 | 4.2 | 4.3 | 3.0 | 3.2 | 0.9 | 10.6 | 4.3 | 3.7 | 4.4 | 3.1 | 4.4 | 3.7 | 3.0 | |
| Net Income | 11.3 | 11.3 | 13.9 | 16.6 | 16.5 | 15.2 | 10.8 | 14.7 | 18.6 | 8.5 | 12.1 | 11.8 | 11.4 | 11.4 | 10.2 | 7.4 | 6.0 |
| Net Income | TTM | 4-2025 | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Interest Income | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | ||
| Interest Expense | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 1.8 | 0.0 | ||
| Other Expense | 0.7 | 0.7 | 0.6 | 0.7 | 0.7 | 0.8 | 0.8 | 0.9 | 1.1 | 0.8 | ||
| IBT | 3.1 | 3.3 | 3.8 | 3.9 | 3.6 | 4.2 | 4.2 | 4.8 | 5.0 | 4.8 | ||
| Income Tax Expense | 0.5 | 0.7 | 0.8 | 0.8 | 0.7 | 0.6 | 0.8 | 0.8 | 0.7 | 0.8 | ||
| Net Income | 2.6 | 2.6 | 3.0 | 3.0 | 2.9 | 3.6 | 3.5 | 4.0 | 4.3 | 3.9 |
| Per Share Data | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| EPS | $0.00 | $0.00 | $0.00 | $4.57 | $4.53 | $4.05 | $2.95 | $3.96 | $4.97 | $2.29 | $3.22 | $3.14 | $3.02 | $3.02 | $2.74 | $2.04 | $1.66 | |
| EPS Diluted | $0.00 | $0.00 | $0.00 | $4.57 | $4.52 | $4.04 | $2.94 | $3.94 | $4.95 | $2.28 | $3.22 | $3.14 | $3.01 | $3.02 | $2.74 | $2.03 | $1.65 | |
| Shares Outstanding | 3.3 | 3.3 | 3.5 | 3.6 | 3.6 | 3.6 | 3.7 | 3.7 | 3.7 | 3.7 | 3.8 | 3.8 | 3.8 | 3.8 | 3.7 | 3.6 | 3.6 | |
| Diluted Shares Outstanding | 3.2 | 3.2 | 3.5 | 3.6 | 3.6 | 3.7 | 3.7 | 3.7 | 3.7 | 3.7 | 3.8 | 3.8 | 3.8 | 3.8 | 3.7 | 3.6 | 3.6 |
| Per Share Data | TTM | 4-2025 | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| EPS | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $1.18 | $1.08 | ||
| EPS Diluted | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $1.18 | $1.08 | ||
| Shares Outstanding | 3.3 | 3.3 | 3.3 | 3.3 | 3.4 | 3.5 | 3.6 | 3.6 | 3.6 | 3.6 | ||
| Diluted Shares Outstanding | 3.2 | 3.2 | 3.2 | 3.3 | 3.4 | 3.5 | 3.5 | 3.6 | 3.6 | 3.6 |
| Current Assets | TTM | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash And Equivalents | 89.2 | 83.0 | 92.9 | 75.1 | 61.0 | 51.6 | 42.8 | 51.1 | 39.9 | 26.4 | 23.3 | 19.3 | 14.5 | 8.9 | 6.6 | 18.5 | |
| Short Term Investments | 178.4 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.0 | 0.1 | 14.7 | |
| Total Cash & ST Investments | 89.2 | 83.0 | 92.9 | 75.1 | 61.0 | 51.6 | 42.8 | 51.1 | 40.0 | 26.4 | 23.3 | 19.3 | 14.5 | 8.9 | 6.6 | 18.5 | |
| Accounts Receivable | 3.7 | 4.1 | 3.3 | 5.5 | 5.1 | 4.1 | 4.7 | 4.0 | 3.6 | 3.2 | 4.6 | 4.7 | 4.4 | 4.3 | 4.7 | 3.2 | |
| Inventory | 9.1 | 8.8 | 9.6 | 8.8 | 6.6 | 6.2 | 6.9 | 5.4 | 5.2 | 4.5 | 4.2 | 4.9 | 4.7 | 4.4 | 5.0 | 3.1 | |
| Other Current Assets | 0.4 | 0.4 | 0.5 | 0.5 | 0.5 | 0.3 | 0.4 | 0.4 | 0.4 | 0.8 | 0.8 | 0.8 | 0.7 | 0.9 | 0.7 | 0.3 | |
| Total Current Assets | 102.3 | 96.3 | 106.3 | 89.9 | 73.2 | 62.3 | 54.9 | 60.9 | 49.2 | 34.9 | 32.9 | 29.7 | 24.3 | 18.5 | 17.0 | 25.1 |
| Current Assets | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | 2-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash And Equivalents | 0.0 | 82.2 | 83.3 | 83.0 | 88.5 | 89.2 | 93.8 | 92.9 | -0.3 | -0.3 | |
| Short Term Investments | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 185.7 | 88.5 | 84.9 | |
| Total Cash & ST Investments | 84.3 | 82.2 | 83.3 | 83.0 | 88.5 | 89.2 | 93.8 | 92.9 | 88.2 | 84.6 | |
| Accounts Receivable | 3.7 | 3.6 | 3.9 | 4.1 | 3.7 | 3.7 | 3.6 | 3.3 | 3.5 | 3.6 | |
| Inventory | 8.1 | 8.2 | 8.6 | 8.8 | 9.1 | 9.1 | 9.2 | 9.6 | 9.7 | 10.1 | |
| Other Current Assets | 0.4 | 0.3 | 0.5 | 0.4 | 0.4 | 0.4 | 0.5 | 0.5 | 0.4 | 0.5 | |
| Total Current Assets | 96.5 | 94.4 | 96.4 | 96.3 | 101.7 | 102.3 | 107.1 | 106.3 | 101.8 | 98.8 |
| Long-Term Assets | TTM | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Property, Plant & Equipment | 10.2 | 9.8 | 10.6 | 10.6 | 11.0 | 11.3 | 10.7 | 10.4 | 11.6 | 10.0 | 7.4 | 8.2 | 8.3 | 8.4 | 8.8 | 8.8 | |
| Goodwill | 13.6 | 13.6 | 13.7 | 13.4 | 14.1 | 14.2 | 14.0 | 13.7 | 14.1 | 13.5 | 14.7 | 15.1 | 15.6 | 15.5 | 15.1 | 7.2 | |
| Intangible Assets | 3.9 | 2.9 | 4.9 | 10.4 | 17.3 | 24.0 | 30.2 | 28.5 | 17.8 | 31.8 | 38.9 | 43.2 | 48.1 | 50.0 | 50.6 | 7.3 | |
| Long-Term Investments | -17.7 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Other Long-Term Assets | 17.5 | 0.0 | 0.0 | -1.5 | 0.0 | 0.0 | 0.0 | 0.0 | -3.1 | -0.4 | -0.4 | 0.0 | 0.0 | -0.5 | 0.0 | -0.2 | |
| Total Long-Term Assets | 27.7 | 26.2 | 29.2 | 34.0 | 42.4 | 49.5 | 54.9 | 38.9 | 43.6 | 41.7 | 46.3 | 51.4 | 56.4 | 58.4 | 59.4 | 16.1 | |
| Total Assets | 130.0 | 122.5 | 135.5 | 123.9 | 115.6 | 111.7 | 109.8 | 99.8 | 92.7 | 76.6 | 79.2 | 81.1 | 80.7 | 76.9 | 76.4 | 41.2 |
| Long-Term Assets | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | 2-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Property, Plant & Equipment | 10.0 | 10.3 | 9.9 | 9.8 | 10.4 | 10.2 | 10.3 | 10.6 | 10.3 | 10.5 | |
| Goodwill | 0.0 | 14.2 | 13.8 | 13.6 | 14.0 | 13.6 | 13.6 | 13.7 | 13.4 | 13.7 | |
| Intangible Assets | 0.0 | 2.0 | 2.4 | 2.9 | 3.6 | 3.9 | 4.4 | 4.9 | 53.0 | 7.5 | |
| Long-Term Investments | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Other Long-Term Assets | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | -0.3 | 0.0 | -0.6 | -0.6 | |
| Total Long-Term Assets | 25.4 | 26.4 | 26.1 | 26.2 | 28.0 | 27.7 | 28.3 | 29.2 | 29.4 | 31.7 | |
| Total Assets | 122.0 | 120.8 | 122.5 | 122.5 | 129.7 | 130.0 | 135.4 | 135.5 | 131.2 | 130.5 |
| Current Liabilities | TTM | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Accounts Payable | 0.8 | 0.5 | 0.8 | 1.2 | 0.8 | 0.8 | 1.1 | 1.0 | 0.9 | 0.9 | 4.1 | 5.1 | 3.6 | 1.0 | 0.9 | 0.4 | |
| Short-Term Debt | 0.0 | 0.1 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 3.9 | 4.1 | 5.4 | 5.4 | 0.2 | |
| Other Current Liabilities | 3.1 | 3.2 | 3.6 | 4.5 | 2.8 | 3.0 | 2.4 | 4.3 | 4.3 | 2.1 | 0.0 | 0.8 | 0.4 | 0.0 | 3.3 | 1.3 | |
| Current Liabilities | 3.9 | 3.8 | 4.7 | 5.8 | 3.6 | 3.8 | 3.4 | 5.3 | 5.3 | 3.0 | 4.1 | 9.0 | 7.6 | 9.2 | 9.6 | 1.9 |
| Current Liabilities | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | 2-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Accounts Payable | 0.8 | 0.7 | 0.9 | 0.7 | 1.0 | 0.8 | 1.0 | 0.8 | 0.5 | 1.3 | |
| Short-Term Debt | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Other Current Liabilities | 2.2 | 1.5 | 3.4 | 3.2 | 2.4 | 2.5 | 3.9 | 3.3 | 3.2 | 3.4 | |
| Current Liabilities | 3.0 | 2.3 | 4.3 | 3.8 | 3.4 | 3.9 | 5.5 | 4.7 | 4.2 | 5.1 |
| Long-Term Liabilities | TTM | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Long-Term Debt | 0.3 | 0.3 | 0.3 | 0.3 | 0.3 | 0.3 | 0.4 | 0.0 | 0.0 | 0.0 | 0.0 | 1.0 | 5.1 | 7.6 | 16.2 | 0.9 | |
| Capital Leases | 0.3 | 0.3 | 0.3 | 0.3 | 0.3 | 0.3 | 0.4 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Def. Tax Liability | 1.1 | 1.1 | 1.4 | 1.5 | 2.1 | 2.8 | 2.8 | 3.1 | 3.6 | 4.3 | 5.5 | 6.6 | 7.5 | 8.8 | 8.5 | 0.6 | |
| Total Liabilities | 6.0 | 5.1 | 7.1 | 9.6 | 8.4 | 8.9 | 8.7 | 10.8 | 14.6 | 7.3 | 9.5 | 16.5 | 20.1 | 26.0 | 35.6 | 3.4 |
| Long-Term Liabilities | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | 2-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Long-Term Debt | 0.2 | 0.3 | 0.3 | 0.3 | 0.3 | 0.3 | 0.3 | 0.3 | 0.3 | 0.3 | |
| Capital Leases | 0.0 | 0.3 | 0.3 | 0.3 | 0.3 | 0.3 | 0.3 | 0.3 | 0.3 | 0.3 | |
| Def. Tax Liability | 0.2 | 0.4 | 0.9 | 1.1 | 1.1 | 1.1 | 1.2 | 1.4 | 1.2 | 1.4 | |
| Total Liabilities | 3.7 | 3.3 | 5.5 | 5.1 | 5.5 | 6.0 | 7.7 | 7.1 | 7.5 | 8.7 |
| Total Common Equity | TTM | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Retained Earnings | 135.3 | 129.3 | 138.3 | 126.0 | 115.3 | 111.0 | 110.8 | 100.1 | 85.6 | 81.1 | 72.9 | 64.9 | 57.3 | 49.5 | 42.9 | 38.9 | |
| Comprehensive Income | -11.3 | -11.9 | -10.7 | -12.0 | -9.1 | -8.3 | -9.8 | -11.3 | -8.3 | -12.2 | -6.0 | -3.2 | 0.0 | -0.9 | -2.9 | -1.3 | |
| Total Common Equity | 124.1 | 117.4 | 128.3 | 114.3 | 107.1 | 102.8 | 101.1 | 89.0 | 78.1 | 69.2 | 69.6 | 64.6 | 60.6 | 51.0 | 40.8 | 37.8 |
| Total Common Equity | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | 2-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Retained Earnings | 0.0 | 126.9 | 128.2 | 129.3 | 134.1 | 135.3 | 139.0 | 138.3 | 135.1 | 132.3 | |
| Comprehensive Income | 0.0 | -9.4 | -11.2 | -11.9 | -9.9 | -11.3 | -11.3 | -10.7 | -12.0 | -11.0 | |
| Total Common Equity | 118.3 | 117.5 | 117.0 | 117.4 | 124.2 | 124.1 | 127.7 | 128.3 | 123.7 | 121.8 |
| Other | TTM | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Debt | 0.3 | 0.3 | 0.3 | 0.3 | 0.3 | 0.3 | 0.4 | 0.0 | 0.0 | 0.0 | 0.0 | 4.9 | 9.1 | 13.0 | 21.7 | 1.1 | |
| Book Value | 124.1 | 117.4 | 128.3 | 114.3 | 107.1 | 102.8 | 101.1 | 89.0 | 78.1 | 69.2 | 69.6 | 64.6 | 60.6 | 51.0 | 40.8 | 37.8 |
| Other | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | 2-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Debt | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Book Value | 118.3 | 117.5 | 117.0 | 117.4 | 124.2 | 124.1 | 127.7 | 128.3 | 123.7 | 121.8 |
| Cash Flow From Operating Activities | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income | 15.6 | 11.3 | 13.9 | 16.6 | 16.5 | 14.8 | 10.8 | 14.7 | 18.6 | 8.5 | 12.1 | 11.8 | 11.4 | 11.4 | 10.2 | 7.4 | 6.0 | |
| Depreciation & Amortization | 4.2 | 0.0 | 2.8 | 6.4 | 7.1 | 7.3 | 7.2 | 6.9 | 3.0 | 2.8 | 2.8 | 3.1 | 3.4 | 3.2 | 3.3 | 2.8 | 0.6 | |
| Stock-Based Compensation | 0.3 | 0.4 | 0.3 | 0.2 | 0.2 | 0.2 | 0.2 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.0 | 0.1 | 0.1 | 0.1 | |
| Change Working Capital | -0.7 | 0.3 | -1.8 | -0.2 | -2.2 | -1.0 | 2.0 | -4.3 | -4.0 | 6.1 | 0.0 | -0.4 | 1.1 | -0.9 | 0.5 | 1.6 | 0.5 | |
| Change In Accounts Receivable | -0.1 | 0.3 | -0.8 | 2.3 | -0.5 | -1.1 | 0.6 | -0.7 | -0.5 | -0.2 | 0.3 | 0.1 | -0.4 | 0.2 | 0.7 | 0.5 | 0.1 | |
| Change In Accounts Payable | -0.5 | 0.2 | -0.1 | -0.5 | 0.5 | 0.0 | -0.3 | 0.1 | 0.1 | 0.0 | 0.3 | -0.3 | 0.2 | -0.2 | 0.1 | -1.2 | 0.1 | |
| Change In Inventories | 1.0 | 1.2 | 0.6 | -0.7 | -2.4 | -0.5 | 0.9 | -1.7 | -0.2 | -0.5 | -0.4 | 0.4 | -0.1 | -0.2 | 0.8 | -0.6 | 0.3 | |
| Other Non-cash Items | 2.7 | 2.7 | -0.3 | 0.0 | 0.0 | 0.1 | 0.0 | 0.1 | -0.4 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.2 | 0.1 | 0.0 | |
| Cash from Operations | 18.5 | 0.0 | 0.0 | 22.3 | 21.1 | 21.2 | 20.1 | 17.1 | 16.8 | 16.9 | 14.5 | 13.8 | 15.4 | 12.3 | 13.6 | 11.4 | 7.2 |
| Cash Flow From Operating Activities | 4-2025 | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income | 2.6 | 2.6 | 3.0 | 3.0 | 2.9 | 3.6 | 3.5 | 4.0 | 4.3 | 3.9 | |
| Depreciation & Amortization | 0.0 | 0.8 | 0.8 | 0.7 | 0.0 | -0.8 | 0.7 | 0.7 | 1.0 | 1.8 | |
| Stock-Based Compensation | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | |
| Change Working Capital | 0.1 | 0.3 | -0.9 | 0.8 | -0.8 | -0.4 | -1.3 | 0.7 | 0.3 | -0.5 | |
| Change In Accounts Receivable | 0.4 | -0.5 | 0.4 | 0.0 | -0.5 | 0.3 | -0.1 | -0.2 | 0.1 | 0.1 | |
| Change In Accounts Payable | 0.1 | 0.0 | -0.2 | 0.2 | -0.3 | 0.2 | -0.2 | 0.2 | 0.3 | -0.8 | |
| Change In Inventories | 0.2 | 0.1 | 0.6 | 0.3 | 0.1 | 0.1 | 0.2 | 0.3 | 0.3 | 0.3 | |
| Other Non-cash Items | 0.7 | 0.4 | 0.0 | 0.0 | 0.7 | 1.5 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Cash from Operations | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 5.3 | 5.1 |
| Cash Flow From Investing Activities | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Capital Expenditure | -0.4 | -0.4 | -0.2 | -0.6 | -0.8 | -0.6 | -0.9 | -21.5 | -0.4 | -1.6 | -3.3 | -0.2 | -1.1 | -0.3 | -0.3 | -0.3 | -1.5 | |
| Acquisitions | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | -41.1 | 0.0 | |
| Investments | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | -0.5 | -1.6 | |
| Sales of Investment | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.1 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 15.2 | 5.8 | |
| Other Investing Activities | -0.8 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.9 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Cash from Investing | -0.4 | 0.0 | 0.0 | -0.6 | -0.8 | -0.6 | -0.9 | -21.5 | 0.5 | -1.6 | -3.3 | -0.2 | -1.1 | -0.3 | -0.2 | -26.7 | 2.7 |
| Cash Flow From Investing Activities | 4-2025 | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Capital Expenditure | -0.4 | 0.0 | -0.1 | -0.2 | 0.0 | 0.1 | -0.1 | 0.0 | -0.1 | -0.2 | |
| Acquisitions | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Investments | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Sales of Investment | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Other Investing Activities | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | -0.8 | 0.0 | |
| Cash from Investing | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | -0.1 | -0.2 |
| Cash Flow From Financing Activities | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debt Repaid | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | -6.6 | -0.3 | -0.3 | -0.5 | -2.5 | 0.0 | -4.8 | -4.0 | -3.9 | -9.1 | -5.9 | -0.4 | |
| Debt Issued | 0.0 | 0.3 | 0.0 | 0.0 | 0.0 | 6.6 | 0.2 | 0.7 | 0.5 | 2.5 | 0.0 | -0.1 | -0.2 | 0.0 | 0.4 | 26.5 | 1.5 | |
| Issuance of Common Stock | 0.5 | 0.0 | 0.0 | 0.1 | 0.2 | 0.4 | 0.3 | 0.3 | 0.5 | 0.4 | 0.3 | 0.3 | 0.8 | 1.8 | 1.8 | 0.5 | 0.4 | |
| Repurchase of Common Stock | -11.9 | -8.4 | -20.0 | -2.5 | -2.5 | -7.0 | -7.0 | -0.4 | -1.2 | -2.9 | -2.9 | -0.7 | -1.1 | -0.5 | -0.5 | 26.9 | -0.4 | |
| Dividends Paid | -4.3 | 0.0 | 0.0 | -4.3 | -3.2 | -11.5 | -4.1 | -4.1 | -4.0 | -3.0 | -3.9 | -3.8 | -3.8 | -3.7 | -3.6 | -3.4 | -6.0 | |
| Other Financing Activities | 0.2 | 0.0 | 0.0 | 0.1 | 0.0 | 13.8 | 0.4 | 0.3 | 0.5 | 5.3 | 0.1 | 0.1 | -0.2 | -0.3 | 0.2 | 0.0 | 0.0 | |
| Cash from Financing | -13.3 | 0.0 | 0.0 | -4.2 | -5.5 | -10.9 | -10.7 | -4.2 | -4.8 | -2.7 | -6.3 | -8.9 | -8.3 | -6.6 | -11.2 | 18.1 | -6.4 |
| Cash Flow From Financing Activities | 4-2025 | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Debt Repaid | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Debt Issued | 0.2 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | -0.1 | 0.0 | 0.0 | |
| Issuance of Common Stock | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.1 | 0.0 | |
| Repurchase of Common Stock | -1.0 | -0.7 | -3.5 | -3.2 | -6.7 | -3.9 | -6.4 | -3.0 | -2.5 | 0.0 | |
| Dividends Paid | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | -1.1 | -1.1 | |
| Other Financing Activities | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Cash from Financing | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | -1.1 | -1.0 |
| Cash position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Change in Cash | 4.6 | 2.8 | -9.9 | 17.8 | 14.1 | 9.4 | 8.8 | -8.3 | 11.2 | 13.6 | 3.0 | 4.0 | 4.9 | 5.5 | 2.3 | 2.7 | 3.4 | |
| Closing Cash Balance | 89.2 | 85.8 | 83.0 | 92.9 | 75.1 | 61.0 | 51.6 | 42.8 | 51.1 | 39.9 | 26.3 | 23.3 | 19.3 | 14.4 | 8.9 | 6.5 | 3.8 |
| Cash position | 4-2025 | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Change in Cash | 1.5 | 2.1 | -1.1 | 0.3 | -5.5 | -0.8 | -4.6 | 0.9 | 4.7 | 3.6 | |
| Closing Cash Balance | 85.8 | 84.3 | 82.2 | 83.3 | 83.0 | 88.5 | 89.2 | 93.8 | 92.9 | 88.2 |
| Free Cash Flow | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Free Cash Flow | 18.1 | 14.3 | 14.6 | 21.6 | 20.3 | 20.7 | 19.3 | -4.5 | 16.4 | 15.3 | 11.2 | 13.6 | 14.3 | 12.0 | 13.3 | 11.1 | 5.6 | |
| Real Free Cash Flow | 17.8 | 13.9 | 14.3 | 21.4 | 20.1 | 20.5 | 19.1 | -4.6 | 16.4 | 15.2 | 11.1 | 13.5 | 14.2 | 11.9 | 13.2 | 11.0 | 5.5 |
| Free Cash Flow | 4-2025 | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Free Cash Flow | -11.6 | 3.9 | 2.8 | 4.3 | 2.9 | 4.0 | 2.6 | 5.3 | 5.2 | 4.9 | |
| Real Free Cash Flow | -11.7 | 3.8 | 2.7 | 4.2 | 2.9 | 3.9 | 2.6 | 5.2 | 5.2 | 4.9 |
Nacenění
Finance
Efektivita
Marže
Dividenda
Ostatní
Nacenění
| Ukazatel | Aktuální | Historické | Konkurence |
|---|---|---|---|
| P/E | 18.3 | 21.3 | 1703.4 |
| P/S | 5.4 | 6.1 | 67.9 |
| P/B | 1.7 | 3 | 25.8 |
| P/FCF | -196.1 | 11.6 | 396.3 |
| Market cap | $0.2 | $0.2 |
P/E (Price to Earnings Ratio) – Poměr ceny akcie k zisku za posledních 12 měsíců. Říká, kolik korun investor zaplatí za 1 korunu zisku. Např.: P/E = 15 znamená, že pokud akcie stojí 15 Kč, firma vydělala 1 Kč za poslední rok.
Finance
| Ukazatel | Aktuální | Historické | Srovnání |
|---|---|---|---|
| Debt to Assets | 0 % | 4.9 % | 0 % |
| Debt to Income | 2.1 % | 48.8 % | 0 % |
| Debt to Free cash flow | -22.9 % | 1861.2 % | 0 % |
| Interest expense percentage | 0 % | -1 % | 38.7 % |
| Current ratio | 32.1 | 11.3 | 0 |
Efektivita
| Ukazatel | Aktuální | Historické | Srovnání |
|---|---|---|---|
| ROE | 9.5 % | 14.9 % | 0 % |
| ROA | 9.3 % | 12.3 % | 0 % |
| CapEx to Revenue | 0.7 % | 5.2 % | 10.6 % |
| RaD to Revenue | 0 % | 1.2 % | 0 % |
| ROEM | 248,509.7 | 208592.8 |
Marže
| Ukazatel | Aktuální | Historické | Srovnání |
|---|---|---|---|
| Gross margin | 52.9 % | 59.4 % | 79.8 % |
| Operating margin | 29.6 % | 36.7 % | 29.6 % |
| Net margin | 29.3 % | 29.2 % | 27.3 % |
Dividenda
| Ukazatel | Aktuální | Historické | Srovnání |
|---|---|---|---|
| Dividend yield | 0 % | 1.9 % | 0 % |
| Dividend payout percentage | 0 % | 35.7 % | 0 % |
Dividend yield (Dividendový výnos) ukazuje aktuální procentuální výnos z dividend vůči ceně akcie.
Ostatní
| Ukazatel | Aktuální | Historické |
|---|---|---|
| Shares outstanding | 3.2 mil | 3.7 mil |
| Employee count | 0.2 tis | 0.2 tis |
Placený obsah
Pro přístup na tuto stránku budete potřebovat placené členství.
Vyzkoušejte placený obsah na akciích: Apple Inc. nebo CEZ, a. s.
Placený obsah
Pro přístup na tuto stránku budete potřebovat placené členství.
Vyzkoušejte placený obsah na akciích: Apple Inc. nebo CEZ, a. s.
Placený obsah
Pro přístup na tuto stránku budete potřebovat placené členství.
Vyzkoušejte placený obsah na akciích: Apple Inc. nebo CEZ, a. s.
Placený obsah
Pro přístup na tuto stránku budete potřebovat placené členství.
Vyzkoušejte placený obsah na akciích: Apple Inc. nebo CEZ, a. s.
Placený obsah
Pro přístup na tuto stránku budete potřebovat placené členství.
Vyzkoušejte placený obsah na akciích: Apple Inc. nebo CEZ, a. s.
